Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Immunomedics, Inc. - Product Pipeline Review - 2014 - New Market Study Published


Print article Print article
2014-03-11 15:05:53 - Fast Market Research recommends "Immunomedics, Inc. - Product Pipeline Review - 2014" from Global Markets Direct, now available

Global Market Direct's pharmaceuticals report, "Immunomedics, Inc. - Product Pipeline Review - 2014" provides data on the Immunomedics, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Immunomedics, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Immunomedics, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Report Scope

* Immunomedics, Inc. - Brief Immunomedics, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Immunomedics, Inc. human therapeutic division.

* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Immunomedics, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Immunomedics, Inc.'s pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Full Report Details at
- www.fastmr.com/prod/778140_immunomedics_inc_product_pipeline_rev ..

Reasons to Get this Report

* Evaluate Immunomedics, Inc.'s strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Immunomedics, Inc. in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Immunomedics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Immunomedics, Inc..
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Immunomedics, Inc. and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
List of Tables
List of Figures
Immunomedics, Inc. Snapshot
Immunomedics, Inc. Overview
Key Information
Key Facts
Immunomedics, Inc. - Research and Development Overview
Key Therapeutic Areas
Immunomedics, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Immunomedics, Inc. - Pipeline Products Glance
Immunomedics, Inc. - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
Immunomedics, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Immunomedics, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Immunomedics, Inc. - Drug Profiles
epratuzumab
Product Description
Mechanism of Action
R&D Progress
yttrium Y 90 clivatuzumab tetraxetan
Product Description
Mechanism of Action
R&D Progress
IMMU-130
Product Description
Mechanism of Action
R&D Progress
IMMU-132
Product Description
Mechanism of Action
R&D Progress
veltuzumab
Product Description
Mechanism of Action
R&D Progress
IMMU-110
Product Description
Mechanism of Action
R&D Progress
milatuzumab
Product Description
Mechanism of Action
R&D Progress
TF-2
Product Description
Mechanism of Action
R&D Progress
IMMU-114
Product Description
Mechanism of Action
R&D Progress
1R-(15)-(15)
Product Description
Mechanism of Action
R&D Progress
1R-(E1)-(E1)
Product Description
Mechanism of Action
R&D Progress
Interferon Lambda-1 Linked Fab Dimer
Product Description
Mechanism of Action
R&D Progress
TF-12
Product Description
Mechanism of Action
R&D Progress
hA19 Antibody
Product Description
Mechanism of Action
R&D Progress
Immunomedics, Inc. - Pipeline Analysis
Immunomedics, Inc. - Pipeline Products by Therapeutic Class
Immunomedics, Inc. - Pipeline Products by Target
Immunomedics, Inc. - Pipeline Products by Route of Administration
Immunomedics, Inc. - Pipeline Products by Molecule Type
Immunomedics, Inc. - Pipeline Products by Mechanism of Action
Immunomedics, Inc. - Recent Pipeline Updates
Immunomedics, Inc. - Dormant Projects
Immunomedics, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
veltuzumab
Immunomedics, Inc. - Company Statement
Immunomedics, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Immunomedics, Inc., Key Information
Immunomedics, Inc., Key Facts
Immunomedics, Inc. - Pipeline by Indication, 2014
Immunomedics, Inc. - Pipeline by Stage of Development, 2014
Immunomedics, Inc. - Monotherapy Products in Pipeline, 2014
Immunomedics, Inc. - Partnered Products in Pipeline, 2014

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=778140&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com